Lv713
4140 积分 2024-05-15 加入
Adjuvant immune checkpoint inhibitors combined with chemotherapy and lenvatinib for biliary tract cancer after curative resection: A single-center retrospective study
6小时前
已完结
Clinical vulnerability to chemotherapy in cholangiocarcinoma: impact of nutritional status, frailty, and systemic inflammation
7小时前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer
1天前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Postoperative adjuvant chemotherapy and chemoimmunotherapy after radical resection for biliary tract cancer: A retrospective study
1天前
已完结
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
1天前
已完结
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
1天前
已完结
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
2天前
已完结
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
2天前
已完结
Intercropping with Peucedanum praeruptorum reshapes rhizosphere microbiome and metabolite to enhance Pseudostellaria heterophylla disease resistance
2天前
已完结
皖公网安备34019202002308
